This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: National Health Research Institutes, National Taiwan University, National Yang Ming Chiao Tung University. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018-2025
Title: Hai-Gwo Hwu: Innovator in Neurological Disorder Treatments
Introduction
Hai-Gwo Hwu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating neurological disorders. With a total of 5 patents to his name, Hwu's work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
Among his latest patents, Hwu has developed substituted benzimidazole derivatives that serve as D-amino acid oxidase (DAAO) inhibitors. This invention provides novel compounds that can be utilized for the treatment and/or prevention of neurological disorders. The innovative approach taken by Hwu in this area showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Hwu has worked with various institutions, including National Taiwan University. His research and development efforts have led to significant advancements in the understanding and treatment of neurological disorders. His dedication to innovation is evident in the patents he has secured, which reflect his expertise and vision in the field.
Collaborations
Hwu has collaborated with notable colleagues, including Yufeng Jane Tseng and Yu-Li Liu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.
Conclusion
Hai-Gwo Hwu is a distinguished inventor whose work in developing DAAO inhibitors has the potential to transform the treatment landscape for neurological disorders. His contributions to science and medicine are commendable, and his ongoing research promises to yield further advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile